There are only 2 stock trades that I have heard mentioned. One was 26 shares of Zimmer Biomet at $104 per share bought along with 69 other stocks on one day by Morgan Stanley in an actively managed brokerage account. This was a periodic rebalancing of his portfolio, done without his input.After these hearings, the only two I think definitely should not be approved are Devos and Price. Devos because she is clearly unqualified and unprepared, Price because of his ethics issues with these repeated stock trades in situations where he either has inside information or is set to act on legislation advantageous to them.
The other was a stock bought by Price with a stock tip from a friend and board member of the company(Innovative something?). Today, Sen. Wyden of Oregon accused Price of using his position to introduce legislation favorable to the company. Price responded by asking Wyden which specific legislation was it that Price introduced. Wyden didn't answer. That trade had no insider information, because the information that he received was publically available. It's BS.